| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/11/2002 | CN1368219A Nano medicine 'Compound Geqing' and its preparing process |
| 09/11/2002 | CN1368217A Nano medicine 'Cangyi nose drops' and its preparing process |
| 09/11/2002 | CN1368216A Nano medicine 'Compound Aidicha' and its preparing process |
| 09/11/2002 | CN1368210A Nano medicine 'Chuanbeili' and its preparing process |
| 09/11/2002 | CN1368206A Nano medicine 'Zhizi Jinhua' and its preparing process |
| 09/11/2002 | CN1368205A Nano medicine 'Zhuhuangchuizhou and its preparing process |
| 09/11/2002 | CN1368204A Nano medicine 'Zhenkening' and its preparing process |
| 09/11/2002 | CN1368200A Nano medicine 'Emuqingfei' and its preparing process |
| 09/11/2002 | CN1368187A Nano medicine 'Tongqiaobiyan' and its preparing process |
| 09/11/2002 | CN1368186A Nano medicine 'Tongguan' and its preparing process |
| 09/11/2002 | CN1368176A Nano medicine 'Reyanning' and its preparing process |
| 09/11/2002 | CN1368171A Nano medicine 'Zhenzhu Lingzhu' and its preparing process |
| 09/11/2002 | CN1368169A Nano medicine 'Gejie Dangshen' and its preparing process |
| 09/11/2002 | CN1368164A Nano medicine 'Kechuanshu' and its preparing process |
| 09/11/2002 | CN1368163A Nano medicine 'Jinglingganmao' and its preparing process |
| 09/11/2002 | CN1368153A Nano medicine 'Hupo Huatanzhenjing' and its preparing process |
| 09/11/2002 | CN1368148A Nano medicine for treating tuberculosis and its preparing process |
| 09/11/2002 | CN1368137A Nano medicine 'Heixi' and its preparing process |
| 09/11/2002 | CN1368132A Nano musk medicine and its preparing process |
| 09/11/2002 | CN1368130A Nano medicine 'Jinsang Liyan' and its preparing process |
| 09/11/2002 | CN1368129A Nano medicine 'Mangshanbai' and its preparing process |
| 09/11/2002 | CN1368126A Nano Laiyang pear medicine and its preparing process |
| 09/11/2002 | CN1368124A Nano medicine for treating stomatitis and its preparing process |
| 09/11/2002 | CN1368119A Nano medicine 'Gushen Dingchuan' and its preparing process |
| 09/11/2002 | CN1368116A Nano medicine 'Yangxin Dingji' and its preparing process |
| 09/11/2002 | CN1368115A Nano medicine 'Yangshen Baofei' and its preparing process |
| 09/11/2002 | CN1368105A Nano antitrussive medicine for infant and its preparing process |
| 09/11/2002 | CN1368104A Nano medicine 'Xiaoerqingjie' and its preparing process |
| 09/11/2002 | CN1368103A Nano Medicine 'Xiaoermagan' and its preparing process |
| 09/11/2002 | CN1368098A Nano antitrussive laiyang pear medicine and its preparing process |
| 09/11/2002 | CN1368092A Nano medicine 'Mahuangzhike' and its preparing process |
| 09/11/2002 | CN1368090A Nano medicine 'Manzhizihong' and its preparing process |
| 09/11/2002 | CN1368085A Nano medicine 'Niuhuang Xiling' and its preparing process |
| 09/11/2002 | CN1368083A Nano medicine 'Pianzaihuang' and its preparing process |
| 09/11/2002 | CN1368070A Nano antitussive medicine 'Jinbaohong' and its preparing process |
| 09/11/2002 | CN1368069A Nano medicine 'Qinghuashangqing' and its preparing process |
| 09/11/2002 | CN1368068A Nano medicine 'Qinghuozhimai' and its preparing process |
| 09/11/2002 | CN1368067A Nano medicine 'Renshenbaofei' and its preparing process |
| 09/11/2002 | CN1368059A Nano medicine 'Hulu' for infant and its preparing process |
| 09/11/2002 | CN1368058A Nano medicine 'Infantile Yanbian' and its preparing process |
| 09/11/2002 | CN1368057A Nano medicine 'Qingyan' and its preparing process |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448284 Substituted tricyclics |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/10/2002 | CA2239159C Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068419A1 Pyridopyrimidine or naphthyridine derivative |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068390A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067967A2 Method of treating rhinitis or sinusitis |
| 09/06/2002 | WO2002067925A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067909A1 New method of bronchodilatory therapy |
| 09/06/2002 | WO2002067902A2 Modulation of release from dry powder formulations |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067831A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002042326A8 A method of expression and agents identified thereby |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002028860A3 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001015553A9 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 09/06/2002 | WO2001002024A9 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2439631A1 Method of treating rhinitis or sinusitis |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2438630A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | CA2438268A1 Modulation of release from dry powder formulations |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2437114A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |